Share Price and Basic Stock Data
Last Updated: February 2, 2026, 3:19 am
| PEG Ratio | -2.93 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Ambica Agarbathies Aroma & Industries Ltd operates in the personal care industry, primarily focusing on the production of agarbathies (incense sticks). The company’s stock price stood at ₹23.5, with a market capitalization of ₹41.8 Cr. Revenue trends over the past quarters indicate fluctuations, with sales recorded at ₹29.20 Cr in September 2022, peaking at ₹35.16 Cr in March 2023, before declining to ₹21.25 Cr in June 2023. The sales rebounded to ₹24.31 Cr in September 2023, but the overall trajectory remains inconsistent when compared to the previous fiscal year, where total sales for FY 2022 were ₹116 Cr, and FY 2023 slightly improved to ₹117 Cr. The trailing twelve months (TTM) revenue stood at ₹132 Cr, indicating a potential recovery. However, the revenue growth remains below the industry average, which generally sees more stable upward trends. This inconsistency may raise concerns among investors regarding the company’s ability to maintain a steady growth trajectory in a competitive market.
Profitability and Efficiency Metrics
Ambica Agarbathies’ profitability metrics reflect significant challenges. The reported operating profit margin (OPM) was 5.28%, which is lower than the typical sector range of 10-15%. The company’s net profit for FY 2025 was ₹0.28 Cr, a stark contrast to the previous fiscal years, where it recorded ₹2 Cr in FY 2022 and ₹3 Cr in FY 2023. The company’s return on equity (ROE) stood at 0.45%, indicating limited profitability relative to shareholder equity. Additionally, the interest coverage ratio (ICR) was reported at 1.43x, suggesting that the company can cover its interest obligations but with limited buffer. The cash conversion cycle (CCC) of 49 days indicates a relatively efficient management of working capital compared to historical figures, but ongoing fluctuations in profitability may deter investor confidence. Overall, while there are signs of operational efficiency, the profitability metrics reveal a need for strategic improvements to enhance margins and returns.
Balance Sheet Strength and Financial Ratios
The balance sheet of Ambica Agarbathies reflects a mixed financial health profile. As of March 2025, the company had total borrowings of ₹84 Cr, with a debt-to-equity ratio of 0.68, suggesting a moderate level of leverage. The reserves stood at ₹95 Cr, indicating a solid accumulation of retained earnings, which could be utilized for future growth initiatives. The book value per share was recorded at ₹63.62, indicating a strong asset base relative to the share price. However, the price-to-book value (P/BV) ratio of 0.42x suggests that the stock is undervalued relative to its net assets, which may signal potential for upside. The current ratio stood at 2.69, indicating good short-term liquidity, while the quick ratio of 2.52 further emphasizes the company’s ability to meet its immediate liabilities. Despite these strengths, the company’s reliance on debt for financing could pose risks in a rising interest rate environment, necessitating careful management of financial obligations.
Shareholding Pattern and Investor Confidence
Ambica Agarbathies’ shareholding pattern reveals a significant concentration of ownership among promoters, who held 43.41% as of June 2025. The public shareholding accounted for 56.58%, indicating a diverse ownership structure. However, the absence of foreign institutional investors (FIIs) raises questions about the company’s attractiveness to larger institutional players. The number of shareholders decreased from 9,256 in December 2022 to 8,669 by September 2025, reflecting a potential decline in investor interest or confidence. This reduction in shareholder numbers could indicate concerns regarding the company’s performance and growth prospects. While the promoter stake remains stable, the increasing public ownership may be a double-edged sword, as it suggests that retail investors have not yet fully embraced the stock. Overall, the shareholding dynamics may affect future capital raising efforts and the company’s strategic initiatives.
Outlook, Risks, and Final Insight
Ambica Agarbathies faces both opportunities and risks in the evolving personal care market. Strengths include a solid reserve base of ₹95 Cr and a low P/BV ratio of 0.42x, indicating potential undervaluation and room for growth. However, profitability remains a concern, as reflected in the low ROE of 0.45% and declining net profits. Risks include reliance on debt, with borrowings at ₹84 Cr, and the potential for increased interest rates impacting financial stability. Furthermore, the volatility in sales figures suggests that the company may struggle to maintain consistent revenue growth. Going forward, the company could focus on enhancing operational efficiencies and exploring new market opportunities to stabilize its financial performance. If Ambica can effectively manage its leverage and improve its profitability metrics, it may regain investor confidence and deliver sustainable growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Honasa Consumer Ltd | 8,980 Cr. | 276 | 334/190 | 72.2 | 38.8 | 0.00 % | 7.44 % | 5.51 % | 10.0 |
| Ambica Agarbathies Aroma & Industries Ltd | 40.4 Cr. | 23.5 | 37.0/22.3 | 79.2 | 65.2 | 0.00 % | 7.49 % | 0.45 % | 10.0 |
| Ador Multi Products Ltd | 116 Cr. | 122 | 149/23.4 | 32.5 | 0.00 % | 11.4 % | 3.09 % | 10.0 | |
| Kaya Ltd | 509 Cr. | 336 | 488/204 | 60.9 | 0.00 % | 2.50 % | % | 10.0 | |
| Jyothy Labs Ltd | 9,106 Cr. | 248 | 423/243 | 24.9 | 55.8 | 1.41 % | 24.6 % | 19.0 % | 1.00 |
| Industry Average | 69,414.14 Cr | 1,871.97 | 53.08 | 112.70 | 0.84% | 29.21% | 23.91% | 4.94 |
All Competitor Stocks of Ambica Agarbathies Aroma & Industries Ltd
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29.20 | 31.95 | 35.16 | 21.25 | 24.31 | 28.93 | 23.35 | 23.01 | 33.51 | 36.05 | 31.05 | 30.14 | 34.63 |
| Expenses | 28.31 | 28.87 | 31.93 | 20.23 | 23.87 | 27.20 | 22.75 | 19.49 | 30.42 | 33.70 | 29.78 | 27.05 | 32.80 |
| Operating Profit | 0.89 | 3.08 | 3.23 | 1.02 | 0.44 | 1.73 | 0.60 | 3.52 | 3.09 | 2.35 | 1.27 | 3.09 | 1.83 |
| OPM % | 3.05% | 9.64% | 9.19% | 4.80% | 1.81% | 5.98% | 2.57% | 15.30% | 9.22% | 6.52% | 4.09% | 10.25% | 5.28% |
| Other Income | 2.76 | 0.72 | 1.88 | 0.01 | 0.49 | 0.03 | 4.82 | 1.05 | 1.42 | 1.51 | 1.33 | 1.74 | 2.14 |
| Interest | 1.74 | 1.76 | 2.51 | 2.06 | 2.09 | 2.07 | 3.49 | 2.65 | 2.84 | 2.93 | 2.44 | 2.72 | 2.32 |
| Depreciation | 0.82 | 0.82 | -0.60 | 0.46 | 0.46 | 0.46 | 0.31 | 0.42 | 0.42 | 0.42 | 0.73 | 0.59 | 0.41 |
| Profit before tax | 1.09 | 1.22 | 3.20 | -1.49 | -1.62 | -0.77 | 1.62 | 1.50 | 1.25 | 0.51 | -0.57 | 1.52 | 1.24 |
| Tax % | -0.00% | -36.89% | 44.69% | 8.72% | -8.02% | -0.00% | 86.42% | 25.33% | 25.60% | 25.49% | 240.35% | 25.00% | 25.00% |
| Net Profit | 1.10 | 1.67 | 1.78 | -1.62 | -1.49 | -0.77 | 0.22 | 1.12 | 0.93 | 0.38 | -1.94 | 1.14 | 0.93 |
| EPS in Rs | 0.64 | 0.97 | 1.04 | -0.94 | -0.87 | -0.45 | 0.13 | 0.65 | 0.54 | 0.22 | -1.13 | 0.66 | 0.54 |
Last Updated: January 9, 2026, 5:47 pm
Below is a detailed analysis of the quarterly data for Ambica Agarbathies Aroma & Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 34.63 Cr.. The value appears strong and on an upward trend. It has increased from 30.14 Cr. (Jun 2025) to 34.63 Cr., marking an increase of 4.49 Cr..
- For Expenses, as of Sep 2025, the value is 32.80 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 27.05 Cr. (Jun 2025) to 32.80 Cr., marking an increase of 5.75 Cr..
- For Operating Profit, as of Sep 2025, the value is 1.83 Cr.. The value appears to be declining and may need further review. It has decreased from 3.09 Cr. (Jun 2025) to 1.83 Cr., marking a decrease of 1.26 Cr..
- For OPM %, as of Sep 2025, the value is 5.28%. The value appears to be declining and may need further review. It has decreased from 10.25% (Jun 2025) to 5.28%, marking a decrease of 4.97%.
- For Other Income, as of Sep 2025, the value is 2.14 Cr.. The value appears strong and on an upward trend. It has increased from 1.74 Cr. (Jun 2025) to 2.14 Cr., marking an increase of 0.40 Cr..
- For Interest, as of Sep 2025, the value is 2.32 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.72 Cr. (Jun 2025) to 2.32 Cr., marking a decrease of 0.40 Cr..
- For Depreciation, as of Sep 2025, the value is 0.41 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.59 Cr. (Jun 2025) to 0.41 Cr., marking a decrease of 0.18 Cr..
- For Profit before tax, as of Sep 2025, the value is 1.24 Cr.. The value appears to be declining and may need further review. It has decreased from 1.52 Cr. (Jun 2025) to 1.24 Cr., marking a decrease of 0.28 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 25.00%.
- For Net Profit, as of Sep 2025, the value is 0.93 Cr.. The value appears to be declining and may need further review. It has decreased from 1.14 Cr. (Jun 2025) to 0.93 Cr., marking a decrease of 0.21 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.54. The value appears to be declining and may need further review. It has decreased from 0.66 (Jun 2025) to 0.54, marking a decrease of 0.12.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:15 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 94 | 98 | 104 | 119 | 125 | 138 | 168 | 143 | 116 | 117 | 98 | 124 | 132 |
| Expenses | 80 | 83 | 91 | 107 | 131 | 126 | 153 | 138 | 102 | 109 | 93 | 113 | 123 |
| Operating Profit | 14 | 14 | 13 | 12 | -5 | 12 | 14 | 6 | 14 | 8 | 5 | 10 | 9 |
| OPM % | 15% | 15% | 12% | 10% | -4% | 9% | 8% | 4% | 12% | 7% | 5% | 8% | 6% |
| Other Income | 1 | 1 | 1 | 2 | 2 | 3 | 0 | 4 | 1 | 5 | 5 | 5 | 7 |
| Interest | 10 | 9 | 9 | 9 | 9 | 8 | 8 | 7 | 12 | 9 | 11 | 11 | 10 |
| Depreciation | 4 | 4 | 3 | 3 | 5 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 2 |
| Profit before tax | 1 | 2 | 2 | 2 | -17 | 4 | 4 | -0 | 1 | 3 | -2 | 3 | 3 |
| Tax % | 20% | 26% | 33% | 32% | 3% | -188% | -17% | -648% | -300% | 17% | 62% | 81% | |
| Net Profit | 1 | 1 | 1 | 2 | -18 | 10 | 4 | 3 | 2 | 3 | -4 | 0 | 1 |
| EPS in Rs | 0.62 | 0.84 | 0.79 | 0.90 | -10.37 | 5.97 | 2.48 | 1.60 | 1.40 | 1.47 | -2.13 | 0.29 | 0.29 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 0.00% | 100.00% | -1000.00% | 155.56% | -60.00% | -25.00% | -33.33% | 50.00% | -233.33% | 100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 0.00% | 100.00% | -1100.00% | 1155.56% | -215.56% | 35.00% | -8.33% | 83.33% | -283.33% | 333.33% |
Ambica Agarbathies Aroma & Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -6% |
| 3 Years: | 2% |
| TTM: | 31% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -21% |
| 3 Years: | -15% |
| TTM: | 155% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | % |
| 3 Years: | -7% |
| 1 Year: | -14% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 1% |
| 3 Years: | 0% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 2:16 pm
Balance Sheet
Last Updated: December 4, 2025, 2:21 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves | 17 | 19 | 19 | 20 | 68 | 76 | 80 | 83 | 85 | 88 | 84 | 92 | 95 |
| Borrowings | 64 | 58 | 58 | 58 | 77 | 67 | 66 | 69 | 64 | 63 | 67 | 82 | 84 |
| Other Liabilities | 23 | 16 | 17 | 19 | 40 | 34 | 41 | 42 | 53 | 36 | 43 | 32 | 29 |
| Total Liabilities | 121 | 110 | 111 | 114 | 202 | 194 | 204 | 212 | 219 | 204 | 211 | 224 | 224 |
| Fixed Assets | 42 | 39 | 38 | 45 | 132 | 129 | 126 | 125 | 122 | 122 | 120 | 130 | 129 |
| CWIP | 12 | 14 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 |
| Investments | 0 | 0 | 0 | 5 | 6 | 6 | 7 | 7 | 8 | 8 | 9 | 10 | 11 |
| Other Assets | 67 | 56 | 63 | 64 | 64 | 59 | 71 | 80 | 90 | 74 | 79 | 84 | 84 |
| Total Assets | 121 | 110 | 111 | 114 | 202 | 194 | 204 | 212 | 219 | 204 | 211 | 224 | 224 |
Below is a detailed analysis of the balance sheet data for Ambica Agarbathies Aroma & Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 17.00 Cr..
- For Reserves, as of Sep 2025, the value is 95.00 Cr.. The value appears strong and on an upward trend. It has increased from 92.00 Cr. (Mar 2025) to 95.00 Cr., marking an increase of 3.00 Cr..
- For Borrowings, as of Sep 2025, the value is 84.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 82.00 Cr. (Mar 2025) to 84.00 Cr., marking an increase of 2.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 29.00 Cr.. The value appears to be improving (decreasing). It has decreased from 32.00 Cr. (Mar 2025) to 29.00 Cr., marking a decrease of 3.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 224.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 224.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 129.00 Cr.. The value appears to be declining and may need further review. It has decreased from 130.00 Cr. (Mar 2025) to 129.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 84.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 84.00 Cr..
- For Total Assets, as of Sep 2025, the value is 224.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 224.00 Cr..
Notably, the Reserves (95.00 Cr.) exceed the Borrowings (84.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -50.00 | -44.00 | -45.00 | -46.00 | -82.00 | -55.00 | -52.00 | -63.00 | -50.00 | -55.00 | -62.00 | -72.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 28 | 32 | 26 | 26 | 36 | 38 | 46 | 21 | 91 | 60 | 35 | 42 |
| Inventory Days | 89 | 129 | 157 | 104 | 7 | 12 | 38 | 42 | 57 | 10 | 30 | 22 |
| Days Payable | 26 | 17 | 25 | 41 | 13 | 12 | 25 | 42 | 108 | 17 | 71 | 15 |
| Cash Conversion Cycle | 91 | 144 | 158 | 89 | 30 | 37 | 59 | 21 | 40 | 53 | -6 | 49 |
| Working Capital Days | 69 | 20 | -19 | -66 | 49 | 68 | 72 | 95 | 111 | 162 | 197 | 144 |
| ROCE % | 11% | 12% | 12% | 11% | -7% | 7% | 7% | 4% | 7% | 7% | 5% | 7% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 4.66 | -2.13 | 1.47 | 1.40 | 1.59 |
| Diluted EPS (Rs.) | 4.66 | -2.13 | 1.47 | 1.40 | 1.59 |
| Cash EPS (Rs.) | 1.45 | -1.15 | 2.54 | 3.30 | 3.43 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 63.62 | 58.96 | 61.09 | 59.63 | 58.24 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 63.62 | 58.96 | 61.09 | 59.63 | 58.24 |
| Revenue From Operations / Share (Rs.) | 71.96 | 56.96 | 68.25 | 67.72 | 83.48 |
| PBDIT / Share (Rs.) | 9.05 | 5.75 | 7.82 | 8.95 | 5.87 |
| PBIT / Share (Rs.) | 7.89 | 4.77 | 6.75 | 7.05 | 4.04 |
| PBT / Share (Rs.) | 1.57 | -1.31 | 1.78 | 0.34 | -0.29 |
| Net Profit / Share (Rs.) | 0.28 | -2.13 | 1.47 | 1.40 | 1.59 |
| PBDIT Margin (%) | 12.58 | 10.10 | 11.45 | 13.21 | 7.03 |
| PBIT Margin (%) | 10.96 | 8.37 | 9.88 | 10.41 | 4.83 |
| PBT Margin (%) | 2.17 | -2.30 | 2.60 | 0.51 | -0.34 |
| Net Profit Margin (%) | 0.39 | -3.74 | 2.15 | 2.06 | 1.90 |
| Return on Networth / Equity (%) | 0.44 | -3.61 | 2.40 | 2.34 | 2.73 |
| Return on Capital Employeed (%) | 6.99 | 4.29 | 6.14 | 6.55 | 3.62 |
| Return On Assets (%) | 0.21 | -1.73 | 1.24 | 1.09 | 1.29 |
| Long Term Debt / Equity (X) | 0.54 | 0.66 | 0.59 | 0.60 | 0.69 |
| Total Debt / Equity (X) | 0.68 | 0.66 | 0.59 | 0.62 | 0.69 |
| Asset Turnover Ratio (%) | 0.56 | 0.47 | 0.55 | 0.54 | 0.68 |
| Current Ratio (X) | 2.69 | 3.66 | 4.51 | 2.08 | 2.96 |
| Quick Ratio (X) | 2.52 | 3.39 | 4.34 | 1.70 | 2.29 |
| Inventory Turnover Ratio (X) | 23.12 | 4.36 | 4.33 | 0.75 | 0.83 |
| Interest Coverage Ratio (X) | 1.43 | 0.94 | 1.57 | 1.34 | 1.36 |
| Interest Coverage Ratio (Post Tax) (X) | 1.04 | 0.64 | 1.30 | 1.21 | 1.37 |
| Enterprise Value (Cr.) | 120.12 | 111.28 | 96.69 | 107.30 | 73.46 |
| EV / Net Operating Revenue (X) | 0.97 | 1.14 | 0.82 | 0.92 | 0.51 |
| EV / EBITDA (X) | 7.72 | 11.26 | 7.20 | 6.98 | 7.28 |
| MarketCap / Net Operating Revenue (X) | 0.37 | 0.46 | 0.29 | 0.38 | 0.04 |
| Price / BV (X) | 0.42 | 0.44 | 0.33 | 0.44 | 0.06 |
| Price / Net Operating Revenue (X) | 0.37 | 0.46 | 0.29 | 0.38 | 0.04 |
| EarningsYield | 0.01 | -0.08 | 0.07 | 0.05 | 0.39 |
After reviewing the key financial ratios for Ambica Agarbathies Aroma & Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 4.66. This value is below the healthy minimum of 5. It has increased from -2.13 (Mar 24) to 4.66, marking an increase of 6.79.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.66. This value is below the healthy minimum of 5. It has increased from -2.13 (Mar 24) to 4.66, marking an increase of 6.79.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.45. This value is below the healthy minimum of 3. It has increased from -1.15 (Mar 24) to 1.45, marking an increase of 2.60.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 63.62. It has increased from 58.96 (Mar 24) to 63.62, marking an increase of 4.66.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 63.62. It has increased from 58.96 (Mar 24) to 63.62, marking an increase of 4.66.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 71.96. It has increased from 56.96 (Mar 24) to 71.96, marking an increase of 15.00.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 9.05. This value is within the healthy range. It has increased from 5.75 (Mar 24) to 9.05, marking an increase of 3.30.
- For PBIT / Share (Rs.), as of Mar 25, the value is 7.89. This value is within the healthy range. It has increased from 4.77 (Mar 24) to 7.89, marking an increase of 3.12.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.57. This value is within the healthy range. It has increased from -1.31 (Mar 24) to 1.57, marking an increase of 2.88.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.28. This value is below the healthy minimum of 2. It has increased from -2.13 (Mar 24) to 0.28, marking an increase of 2.41.
- For PBDIT Margin (%), as of Mar 25, the value is 12.58. This value is within the healthy range. It has increased from 10.10 (Mar 24) to 12.58, marking an increase of 2.48.
- For PBIT Margin (%), as of Mar 25, the value is 10.96. This value is within the healthy range. It has increased from 8.37 (Mar 24) to 10.96, marking an increase of 2.59.
- For PBT Margin (%), as of Mar 25, the value is 2.17. This value is below the healthy minimum of 10. It has increased from -2.30 (Mar 24) to 2.17, marking an increase of 4.47.
- For Net Profit Margin (%), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 5. It has increased from -3.74 (Mar 24) to 0.39, marking an increase of 4.13.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 15. It has increased from -3.61 (Mar 24) to 0.44, marking an increase of 4.05.
- For Return on Capital Employeed (%), as of Mar 25, the value is 6.99. This value is below the healthy minimum of 10. It has increased from 4.29 (Mar 24) to 6.99, marking an increase of 2.70.
- For Return On Assets (%), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 5. It has increased from -1.73 (Mar 24) to 0.21, marking an increase of 1.94.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.54. This value is within the healthy range. It has decreased from 0.66 (Mar 24) to 0.54, marking a decrease of 0.12.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.68. This value is within the healthy range. It has increased from 0.66 (Mar 24) to 0.68, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.56. It has increased from 0.47 (Mar 24) to 0.56, marking an increase of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 2.69. This value is within the healthy range. It has decreased from 3.66 (Mar 24) to 2.69, marking a decrease of 0.97.
- For Quick Ratio (X), as of Mar 25, the value is 2.52. This value exceeds the healthy maximum of 2. It has decreased from 3.39 (Mar 24) to 2.52, marking a decrease of 0.87.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 23.12. This value exceeds the healthy maximum of 8. It has increased from 4.36 (Mar 24) to 23.12, marking an increase of 18.76.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.43. This value is below the healthy minimum of 3. It has increased from 0.94 (Mar 24) to 1.43, marking an increase of 0.49.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 3. It has increased from 0.64 (Mar 24) to 1.04, marking an increase of 0.40.
- For Enterprise Value (Cr.), as of Mar 25, the value is 120.12. It has increased from 111.28 (Mar 24) to 120.12, marking an increase of 8.84.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 1. It has decreased from 1.14 (Mar 24) to 0.97, marking a decrease of 0.17.
- For EV / EBITDA (X), as of Mar 25, the value is 7.72. This value is within the healthy range. It has decreased from 11.26 (Mar 24) to 7.72, marking a decrease of 3.54.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.46 (Mar 24) to 0.37, marking a decrease of 0.09.
- For Price / BV (X), as of Mar 25, the value is 0.42. This value is below the healthy minimum of 1. It has decreased from 0.44 (Mar 24) to 0.42, marking a decrease of 0.02.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.46 (Mar 24) to 0.37, marking a decrease of 0.09.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.08 (Mar 24) to 0.01, marking an increase of 0.09.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ambica Agarbathies Aroma & Industries Ltd:
- Net Profit Margin: 0.39%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 6.99% (Industry Average ROCE: 29.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.44% (Industry Average ROE: 23.91%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.04
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.52
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 79.2 (Industry average Stock P/E: 53.08)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.68
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.39%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | Shankar Towers, Power Pet, Eluru, West Godavari Dist. Andhra Pradesh 534002 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ambica Krishna | Chairman & Managing Director |
| Mrs. Satyavathi Perla | Whole Time Director |
| Mr. Ambica Ramachandra Rao | Whole Time Director |
| Mr. Chunduru Anjaneya Swamy | Independent Director |
| Mr. B V Subrahmanyeswarao | Independent Director |
| Mr. Mallikarjunarao Voleti | Independent Director |
FAQ
What is the intrinsic value of Ambica Agarbathies Aroma & Industries Ltd?
Ambica Agarbathies Aroma & Industries Ltd's intrinsic value (as of 02 February 2026) is ₹13.84 which is 41.11% lower the current market price of ₹23.50, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹40.4 Cr. market cap, FY2025-2026 high/low of ₹37.0/22.3, reserves of ₹95 Cr, and liabilities of ₹224 Cr.
What is the Market Cap of Ambica Agarbathies Aroma & Industries Ltd?
The Market Cap of Ambica Agarbathies Aroma & Industries Ltd is 40.4 Cr..
What is the current Stock Price of Ambica Agarbathies Aroma & Industries Ltd as on 02 February 2026?
The current stock price of Ambica Agarbathies Aroma & Industries Ltd as on 02 February 2026 is ₹23.5.
What is the High / Low of Ambica Agarbathies Aroma & Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Ambica Agarbathies Aroma & Industries Ltd stocks is ₹37.0/22.3.
What is the Stock P/E of Ambica Agarbathies Aroma & Industries Ltd?
The Stock P/E of Ambica Agarbathies Aroma & Industries Ltd is 79.2.
What is the Book Value of Ambica Agarbathies Aroma & Industries Ltd?
The Book Value of Ambica Agarbathies Aroma & Industries Ltd is 65.2.
What is the Dividend Yield of Ambica Agarbathies Aroma & Industries Ltd?
The Dividend Yield of Ambica Agarbathies Aroma & Industries Ltd is 0.00 %.
What is the ROCE of Ambica Agarbathies Aroma & Industries Ltd?
The ROCE of Ambica Agarbathies Aroma & Industries Ltd is 7.49 %.
What is the ROE of Ambica Agarbathies Aroma & Industries Ltd?
The ROE of Ambica Agarbathies Aroma & Industries Ltd is 0.45 %.
What is the Face Value of Ambica Agarbathies Aroma & Industries Ltd?
The Face Value of Ambica Agarbathies Aroma & Industries Ltd is 10.0.